TotalMarketCap

GH Research

GHRSNasdaq IrelandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.261 B

$18.40 -7.68%

Close of 6 Nov 2026

As of 6 Nov 2026, GH Research (GHRS) has a market capitalization of $1.26B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

62,029,395

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #130KardiganKARD$1.30B
  2. #131Opko HealthOPK$1.30B
  3. #132GH ResearchGHRS$1.26B
  4. #133UroGen PharmaURGN$1.26B
  5. #134Nektar TherapeuticsNKTR$1.24B

What if GH Research were worth as much as…

Open the what-if tool →

Gold $28.2T

$411,873.36

Per share 22,384× higher

Bitcoin $1.53T

$22,285.75

Per share 1,211× higher

Apple $5.02T

$73,162.04

Per share 3,976× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for GH Research are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.